Profound Medical (NASDAQ:PROF) PT Set at $23.00 by Raymond J

Profound Medical (NASDAQ:PROF – Get Rating) has been assigned a $23.00 price target by research analysts at Raymond James in a research report issued to clients and investors on Wednesday, BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Raymond James’ price objective indicates a potential upside of 145.20% from the company’s […]

Related Keywords

Raymond Jame , Raymond James , Company Profile Get Rating , Geode Capital Management , Harbor Advisors , Zacks Investment Research , De Shaw Co , Nasdaq , Investment Management , Profound Medical , Get Rating , Capital Management , Medical Company Profile , Nasdaq Prof , Prof , Medical , Set Price Target ,